acitretin has been researched along with Neoplasm Metastasis, Unknown Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenchel, K; Sachse, MM; Wagner, G | 1 |
Hertel, K; Höffken, K; Kloos, C; Metzner, U; Müller, UA; Raabe, G; Schreiber, J | 1 |
2 other study(ies) available for acitretin and Neoplasm Metastasis, Unknown Primary
Article | Year |
---|---|
Regression of B-RAF inhibitor associated keratoacanthomas by acitretin - how do retinoids act on the RAF/MEK/ERK-signaling pathway?
Topics: Acitretin; Adult; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Eyelid Diseases; Female; Humans; Indoles; Keratoacanthoma; Lung Neoplasms; Lymphatic Metastasis; MAP Kinase Kinase 1; MAP Kinase Signaling System; Melanoma; Neoplasm Staging; Neoplasms, Unknown Primary; Proto-Oncogene Proteins B-raf; Signal Transduction; Sulfonamides; Vemurafenib | 2014 |
[Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary].
Topics: Acitretin; Adenocarcinoma; Aged; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Keratolytic Agents; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Pityriasis Rubra Pilaris; Prednisolone; Skin | 2002 |